Literature DB >> 7555180

Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects.

J Hirsh, J E Dalen, V Fuster, L B Harker, C Patrono, G Roth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7555180     DOI： 10.1378/chest.108.4_supplement.247s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

Review 1.  Aspirin in patients with coronary artery disease: is it simply irresistible?

Authors:  G V Nair; C J Davis; M E McKenzie; D R Lowry; V L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

Review 2.  [Therapy of acute coronary syndrome. Aspirin, heparin, low-molecular-weight heparin, hirudin and GP-IIb/IIIa blockers].

Authors:  A Gaede; W Terres
Journal:  Herz       Date:  1999-08       Impact factor: 1.443

Review 3.  Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.

Authors:  R M Zusman; J H Chesebro; A Comerota; J R Hartmann; E K Massin; E Raps; P A Wolf
Journal:  Clin Cardiol       Date:  1999-09       Impact factor: 2.882

4.  Gastric protection and gastrointestinal bleeding with aspirin thromboprophylaxis in hip and knee joint replacements.

Authors:  T R Madhusudhan; A Rangan; P J Gregg
Journal:  Ann R Coll Surg Engl       Date:  2008-05       Impact factor: 1.891

5.  Diabetic muscle infarction: a systematic review.

Authors:  William B Horton; Jeremy S Taylor; Timothy J Ragland; Angela R Subauste
Journal:  BMJ Open Diabetes Res Care       Date:  2015-04-24

Review 6.  Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview.

Authors:  Lian Duan; Xingjiang Xiong; Junyuan Hu; Yongmei Liu; Jun Li; Jie Wang
Journal:  Front Pharmacol       Date:  2017-10-17       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.